Insider John Couling to sell Dolby (DLB) shares worth about $432K
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
Dolby Laboratories insider John Couling has filed to sell additional common shares under Rule 144. The notice covers 6,667 common shares to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on or about 02/02/2026, with an aggregate market value of 432,588.30. The filing notes 60,884,768 common shares outstanding and lists the NYSE as the trading venue.
The shares to be sold were originally acquired from the issuer as restricted stock and performance shares on various grant dates between 12/15/2020 and 12/15/2023. Over the past three months, Couling previously sold 7,273 common shares on 12/11/2025 for gross proceeds of 500,018.75 and 6,164 common shares on 11/20/2025 for gross proceeds of 407,563.68.
Positive
- None.
Negative
- None.
FAQ
What does the latest Rule 144 filing for Dolby (DLB) disclose?
The filing shows insider John Couling plans to sell 6,667 Dolby common shares. The planned sale has an aggregate market value of 432,588.30 and will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on or about 02/02/2026 on the NYSE.
What recent Dolby (DLB) stock sales has John Couling already completed?
Over the past three months, John Couling sold 7,273 Dolby common shares on 12/11/2025 and 6,164 shares on 11/20/2025. These transactions generated gross proceeds of 500,018.75 and 407,563.68 respectively, reflecting prior insider selling activity before the newly filed planned sale.
Through which broker and exchange will the Dolby (DLB) insider sale occur?
The planned sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The filing identifies the NYSE as the securities exchange for the 6,667 Dolby common shares scheduled for sale on or about 02/02/2026 under Rule 144.